article thumbnail

Understanding the Impact of the New EU Artificial Intelligence Act on Clinical Research

Advarra

The EU AI Act’s implications extend into clinical research, where AI is increasingly utilized for tasks like medical image analysis, natural language process for endpoint analysis, and generating/analyzing data for synthetic control arms. A version of this article originally appeared in PharmaPhorum in July 2024.

article thumbnail

1 in 5 U.S. Cancer Patients Join in Medical Research

Drugs.com

WEDNESDAY, April 3, 2024 -- More patients these days are taking part in cancer research, a new study finds. At least one in five people with cancer (22%) participate in some form of clinical research, when all types of cancer studies are.

Research 186
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Clinical Research Conferences of 2024

Vial

The field of clinical research is a dynamic and rapidly evolving one. One way to ensure that you are at the forefront of these developments is by attending clinical research conferences. In 2024, an array of these conferences are scheduled to take place across the world. Learn more on their website here.

article thumbnail

The Power of Worldwide Networks in Data and Safety Monitoring Boards

Advarra

Data and safety monitoring boards (DSMBs), also known as data monitoring committees (DMCs), play a critical role in overseeing a clinical trial’s safety and efficacy. The February 2024 FDA draft guidance on DMCs highlights the necessity of incorporating diverse, global expertise into these critical oversight functions.

article thumbnail

TrialKit AI: Revolutionizing Clinical Research Analytics with AI

Crucial Data Solutions

December 9, 2024— Crucial Data Solutions is proud to announce that our groundbreaking innovation, TrialKit AI, has been recognized with. The post TrialKit AI: Revolutionizing Clinical Research Analytics with AI appeared first on Crucial Data Solutions.

article thumbnail

Five Predictions for the Biopharma and Biotech Industries in 2024

PPD

These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. To get a pulse on the changing industry, the PPD clinical research business of Thermo Fisher Scientific surveyed 150 biotech and biopharma leaders for the second year in a row to illuminate industry trends, challenges and sentiments.

article thumbnail

Redefining Acceleration of the Drug Development Journey

PPD

According to the United Nation’s 2024 World Population Prospects data, the global population of those 65 years old and over will grow from 0.8 From an aging population increasing health care demand to urgent, unmet medical needs, there are clear drivers to advance safe and effective medicines to patients faster than ever. billion in 2035.